{
  "paper_metadata": {
    "pmid": "28944235",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant c.424G>A (p.Val142Ile) including clinical significance, penetrance data, and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.424G>A",
      "protein_notation": "p.Val142Ile",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 192,
        "demographics": "healthy unrelated individuals, predominantly female, from Puerto Rican, African American, and Dominican backgrounds",
        "phenotype": "transthyretin amyloidosis typically manifests after age 60 with renal amyloidosis and cardiomyopathy"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The variant is associated with transthyretin amyloidosis, which typically presents with renal amyloidosis and cardiomyopathy.",
        "assays": []
      },
      "segregation_data": "Not specified in the paper.",
      "population_frequency": "Not specified in the paper.",
      "evidence_level": "Moderate evidence based on literature review and clinical significance.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is noted to disproportionately affect African Americans.",
      "key_quotes": [
        "transthyretin amyloidosis (TTRNM_000371.3:c.424G>A(p.Val142Ile)) that typically manifests after age 60 with renal amyloidosis and cardiomyopathy"
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Only one variant in the TTR gene was found in the text."
  }
}